Brief: Exopharm Says Signs Binding Agreement To Acquire Tryp Therapeutics
08/03/2024 01:29
March 8 (Reuters) - Exopharm EX1.AX :
* SIGNS BINDING AGREEMENT TO ACQUIRE TRYP THERAPEUTICS
* EXOPHARM INTENDS TO RAISE UP TO A$6.5 MILLION VIA A PUBLIC
OFFER
* UNDERTAKEN INTERIM CAPITAL RAISE BY WAY OF CONVERTIBLE
NOTE OF
A$3.39 MILLION
* ACQUISITION WILL AMOUNT TO SIGNIFICANT CHANGE TO NATURE
AND
SCALE OF CO'S ACTIVITIES
* ISSUE PRICE OF A$0.02 PER SHARE FOR PUBLIC OFFER
* TO RAISE UP TO A$6.5 MILLION TO SUPPORT RESEARCH AND
DEVELOPMENT
OF TRYP'S LEAD PROGRAMS
Source text for Eikon: ID:nASX6SHf0b
Further company coverage: EX1.AX
((Reuters.Briefs@thomsonreuters.com;))